Should genetic information be disclosed to insurers? YesBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39216.468495.AD (Published 07 June 2007) Cite this as: BMJ 2007;334:1196
- Søren Holm, professor
- Centre for Ethics, Law and Society, Cardiff Law School, Cardiff CF10 3AX and Section for Medical Ethics, University of Oslo, Oslo
The main argument for disclosing genetic information to insurers is that there are no good reasons for not disclosing it. If we accept that life or health insurers can legitimately seek and obtain other kinds of health information that predicts insurance risk, then we should also accept that they can seek genetic information that is predictive in the same way. There is no reason for treating genetic information differently.
What is the purpose of insurance?
The main purpose of life or health insurance is to spread the costs of expensive but unpredictable events across the pool of the insured, thereby converting a possibly catastrophic loss to a predictable regular expenditure. The actuarially fair price is the price that adequately reflects my risk plus the administration costs. This is, for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial